SCNI Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$4.87 M
-$9.21 M-65.40%

December 31, 2023


Summary


Performance

SCNI Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSCNIbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$1.03 M
-$2.04 M-66.45%

September 1, 2024


Summary


Performance

SCNI Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSCNIbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

SCNI Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-65.4%-78.6%
3 y3 years+66.2%-92.7%
5 y5 years-75.8%-92.7%

SCNI Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-72.0%at low-94.1%at low
5 y5-year-76.7%+66.2%-95.1%at low
alltimeall time-76.7%+97.3%-95.3%at low

Scinai Immunotherapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$1.03 M(-66.4%)
Jun 2024
-
$3.08 M(-36.3%)
Mar 2024
-
$4.83 M(-0.9%)
Dec 2023
$4.87 M(-65.4%)
$4.87 M(-23.5%)
Sep 2023
-
$6.36 M(-15.2%)
Jun 2023
-
$7.51 M(-30.5%)
Mar 2023
-
$10.80 M(-23.3%)
Dec 2022
$14.07 M(-19.0%)
$14.07 M(+70.4%)
Sep 2022
-
$8.26 M(-27.4%)
Jun 2022
-
$11.38 M(-26.0%)
Mar 2022
-
$15.37 M(-11.5%)
Dec 2021
$17.37 M(+493.0%)
-
Dec 2021
-
$17.37 M(+61.4%)
Sep 2021
-
$10.77 M(-12.1%)
Jun 2021
-
$12.25 M(-15.8%)
Mar 2021
-
$14.55 M(+396.5%)
Dec 2020
$2.93 M(-86.0%)
$2.93 M(-59.2%)
Sep 2020
-
$7.18 M(-36.1%)
Jun 2020
-
$11.24 M(-46.3%)
Dec 2019
$20.93 M
$20.93 M(-3.1%)
Sep 2019
-
$21.60 M(+127.6%)
DateAnnualQuarterly
Jun 2019
-
$9.49 M(-40.2%)
Mar 2019
-
$15.86 M(-21.3%)
Dec 2018
$20.15 M(-1.9%)
$20.15 M(+37.4%)
Sep 2018
-
$14.67 M(+44.5%)
Jun 2018
-
$10.15 M(-36.0%)
Mar 2018
-
$15.85 M(-22.8%)
Dec 2017
$20.54 M(+403.0%)
$20.54 M(-5.7%)
Sep 2017
-
$21.78 M(+142.5%)
Jun 2017
-
$8.98 M(+35.5%)
Mar 2017
-
$6.63 M(+62.4%)
Dec 2016
$4.08 M(-52.4%)
$4.08 M(+1.6%)
Sep 2016
-
$4.02 M(+2.8%)
Jun 2016
-
$3.91 M(-50.4%)
Mar 2016
-
$7.89 M(-8.0%)
Dec 2015
$8.57 M(+247.3%)
$8.57 M(-7.2%)
Sep 2015
-
$9.24 M(-8.0%)
Jun 2015
-
$10.04 M(+437.2%)
Mar 2015
-
$1.87 M(-24.3%)
Dec 2014
$2.47 M(-51.9%)
$2.47 M(-26.7%)
Sep 2014
-
$3.37 M(-34.3%)
Dec 2013
$5.13 M(+73.8%)
$5.13 M
Dec 2012
$2.95 M
-

FAQ

  • What is Scinai Immunotherapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics annual cash & cash equivalents year-on-year change?
  • What is Scinai Immunotherapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics quarterly cash and cash equivalents year-on-year change?

What is Scinai Immunotherapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of SCNI is $4.87 M

What is the all time high annual cash & cash equivalents for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high annual cash & cash equivalents is $20.93 M

What is Scinai Immunotherapeutics annual cash & cash equivalents year-on-year change?

Over the past year, SCNI annual cash & cash equivalents has changed by -$9.21 M (-65.40%)

What is Scinai Immunotherapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of SCNI is $1.03 M

What is the all time high quarterly cash and cash equivalents for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high quarterly cash and cash equivalents is $21.78 M

What is Scinai Immunotherapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, SCNI quarterly cash and cash equivalents has changed by -$3.79 M (-78.62%)